g Instructions for use
Materials used
Introcan Safety® is available in two materials:
FEP, PP, ABS, chrome-nickel steel
PUR, PP, ABS, chrome-nickel steel
Indications
The Introcan Safety® Intravascular catheter is in-
serted into a patient´s vascular system for short
term use (less than 30 days) to sample blood, moni-
tor blood pressure, or administer fluids and blood
intravascularly.
The Introcan Safety® is also indicated for subcuta-
neous infusion therapies.
14-24 gauge catheters may be used with power
injectors for which the maximum pressure setting
is 300 psi/21 bar.
Use luer lock connection only.
See table below for recommended maximum flow
rates for the Introcan Safety® IV Catheter when
using a power injector. Testing performed at room
temperature (22°C / 72°F). Warming contrast media
per manufacturers' recommendations, can reduce
the pressure necessary to achieve recommended
flow rates.
24 Gauge all lengths
22 Gauge
20 Gauge
18 Gauge all lengths
- 8 -
7948_Introcan Safety_EU_AP_SA_IFU_1217.indd 8
Contrast Media
Flow Rate
(Viscosity at
20°C) [mPa*s]
2,3
27,5
2,3
G22x25
27,5
2,3
G22x64
27,5
G20x25
2,3
G20x32
27,5
G20x45
2,3
G20x64
27,5
2,3
27,5
The above are flow rates tested in a laboratory
setting and are the maximum flow rates our IV
Catheters are able to achieve and do not constitute
guarantees, warranties, or predictions regarding the
outcome of your matter.
In any case, it is the responsibility of the user to
accommodate the flow rates to each patient´s con-
ditions and / or therapy needed.
Facilitate the placement of Vascular Access Devices
such as guidewires, indwelling central venous cath-
eters, peripherally inserted central catheters, and
midline catheters into the vascular system.
Contraindications
Introcan Safety® I. V. Catheter should not be used in
patients with known hypersensitivity to any of the
materials employed.
Risks
This I. V. catheter is designed to reduce the risk
of accidental needlesticks; however, care must be
taken to avoid needlesticks. Report needlesticks im-
mediately and follow established protocols. Stand-
ard precautions must be adhered to in accordance
with Centers for Disease Control and Prevention /
Occupational Safety and Health Administration
(CDC/ OSHA) standards for bloodborne pathogens,
when starting or maintaining any I. V. catheter, to
(ml/sec)
avoid the risk of exposure to contaminated blood.
Depending on how long the catheter is left in situ,
5
on the type and amount of infusions or injections
2,5
administered, and on individual predisposition,
8
thrombophlebitis may occur in the accessed vein.
5
In arterial puncture, the artery may occlude in rare
7
cases due to thrombotic or embolic complications,
3
resulting in ischaemia.
14
Duration of use
10
Change according to CDC Guidelines and / or Hos-
13
pital or Institutional protocols. The puncture site
8
should be checked at regular intervals. Introcan
19
Safety® I. V. Catheter should be removed in the
15
event of local or systemic signs of infection.
14.12.17 11